Here are four highlights:
1. As predicted, Stryker acquired the ENT company for $662 million.
2. Entellus Medical focuses on providing minimally invasive solutions for various ear, nose and throat conditions.
3. Entellus Medical has a range of products, including the XprESS multi-sinus dilation system and Latera absorbable nasal implant.
4. The acquisition is anticipated to dilute Stryker’s 2018 adjusted net earnings by $0.04 per share.
More articles on devices and implants:
Medtronic, Stryker, Smith & Nephew and DePuy Synthes lead global orthopedics market — 5 observations
Leader Biomedical to acquire International Orthopaedics, expand global operations: 3 insights
ConforMIS iTotal CR knee replacement system awarded 3A rating: 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
